PDS Biotechnology Corp (PDSB)
3.82
+0.09
(+2.41%)
USD |
NASDAQ |
May 03, 16:00
3.825
0.00 (0.00%)
After-Hours: 20:00
PDS Biotechnology Cash and Short Term Investments (Quarterly): 56.56M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 56.56M |
September 30, 2023 | 54.25M |
June 30, 2023 | 60.62M |
March 31, 2023 | 65.20M |
December 31, 2022 | 73.82M |
September 30, 2022 | 71.64M |
June 30, 2022 | 52.98M |
March 31, 2022 | 58.88M |
December 31, 2021 | 65.24M |
September 30, 2021 | 69.74M |
June 30, 2021 | 74.75M |
March 31, 2021 | 25.04M |
December 31, 2020 | 28.84M |
September 30, 2020 | 33.47M |
June 30, 2020 | 16.93M |
March 31, 2020 | 21.04M |
December 31, 2019 | 12.16M |
September 30, 2019 | 17.41M |
Date | Value |
---|---|
June 30, 2019 | 21.73M |
March 31, 2019 | 26.59M |
December 31, 2018 | 34.65M |
September 30, 2018 | 36.81M |
June 30, 2018 | 45.98M |
March 31, 2018 | 75.00M |
December 31, 2017 | 88.07M |
September 30, 2017 | 97.31M |
June 30, 2017 | 108.71M |
March 31, 2017 | 95.59M |
December 31, 2016 | 106.40M |
September 30, 2016 | 112.78M |
June 30, 2016 | 111.02M |
March 31, 2016 | 119.94M |
December 31, 2015 | 130.19M |
September 30, 2015 | 52.88M |
June 30, 2015 | 58.47M |
December 31, 2014 | 13.73M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
12.16M
Minimum
Dec 2019
74.75M
Maximum
Jun 2021
46.33M
Average
54.25M
Median
Sep 2023
Cash and Short Term Investments (Quarterly) Benchmarks
Syros Pharmaceuticals Inc | 139.53M |
PAVmed Inc | 19.64M |
Altimmune Inc | 197.82M |
Regeneron Pharmaceuticals Inc | 10.52B |
iBio Inc | 2.788M |